Financials
Income statement
Fiscal date | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 |
---|---|---|---|---|
Total reported revenue | 15.9B | 14.1B | 14.1B | 13.3B |
Cost of revenue | 4.7B | 4.2B | 4.1B | 3.9B |
Gross profit | 11.2B | 9.9B | 10.0B | 9.4B |
Operating expense | ||||
Research & development | 2.7B | 2.4B | 2.5B | 2.3B |
Selling general and admin | 2.8B | 2.5B | 2.6B | 2.4B |
Other operating expenses | — | — | — | — |
Operating income | 5.2B | 4.4B | 4.3B | 4.1B |
Non operating interest income | ||||
Income | 160M | 135M | 149M | 133M |
Expense | 978M | 892M | 866M | 842M |
Other income expense | -221M | -244M | -228M | -199M |
Pretax income | 4.2B | 3.4B | 3.4B | 3.2B |
Tax provision | 725M | 512M | 239M | 240M |
Net income | 3.4B | 2.9B | 3.2B | 2.9B |
Basic EPS | — | 1.1 | 1.1 | 1.1 |
Diluted EPS | — | 1.0 | 1.1 | 1.0 |
Basic average shares | — | 2.8B | 2.8B | 2.8B |
Diluted average shares | — | 2.9B | 2.9B | 2.9B |
EBITDA | 7.0B | 6.1B | 6.0B | 5.6B |
Net income from continuing op. | 3.4B | 2.9B | 3.2B | 2.9B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |